Are cerebrovascular factors involved in Alzheimer's disease?

被引:64
作者
Kudo, T
Imaizumi, K
Tanimukai, H
Katayama, T
Sato, N
Nakamura, Y
Tanaka, T
Kashiwagi, Y
Jinno, Y
Tohyama, M
Takeda, M
机构
[1] Osaka Univ, Grad Sch Med, Dept Clin Neurosci Psychiat, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka 5650871, Japan
[3] Tanabe Seiyaku Co Ltd, Yodogawa Ku, Osaka 5320031, Japan
关键词
Alzheimer's disease; cerebrovascular disorder; vascular dementia; risk factor; presenilin;
D O I
10.1016/S0197-4580(00)00129-9
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Recent epidemiological studies have shown that vascular risk factors may be involved in Alzheimer's disease (AD) as well as dementia in general. To investigate the relation between a vascular disorder and AD pathology, current criteria are defective because most depend on exclusion of a cerebrovascular disorder. Epidemiological studies have indicated the possibilities that arteriosclerosis, abnormal blood pressure, diabetes mellitus and smoking may be related to the pathogenesis of AD. As for the mechanism that vascular disorders influence AD, it is presumed that amyloid deposition may be caused by a vascular disorder. Alternatively, a vascular event may cause progression of subclinical AD to a clinical stage. Insulin resistance and apolipoprotein E may also be involved in these mechanisms. Our studies show that ischemia-induced the Alzheimer-associated gene presenilin 1 (PS1) and endoplasmic reticulum-stress, generated from a vascular disorder, may unmask clinical AD symptoms caused by presenilin mutation, suggesting that a vascular factor might be involved in the onset of familial AD. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:215 / 224
页数:10
相关论文
共 50 条
[1]   DIFFERENTIAL-EFFECTS OF INSULIN ON CHOLINE-ACETYLTRANSFERASE AND GLUTAMIC-ACID DECARBOXYLASE ACTIVITIES IN NEURON-RICH STRIATAL CULTURES [J].
BRASS, BJ ;
NONNER, D ;
BARRETT, JN .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (02) :415-424
[2]   CARDIOVASCULAR-DISEASE AND DISTRIBUTION OF COGNITIVE FUNCTION IN ELDERLY PEOPLE - THE ROTTERDAM STUDY [J].
BRETELER, MMB ;
CLAUS, JJ ;
GROBBEE, DE ;
HOFMAN, A .
BRITISH MEDICAL JOURNAL, 1994, 308 (6944) :1604-1608
[3]   CEREBRAL WHITE-MATTER LESIONS, VASCULAR RISK-FACTORS, AND COGNITIVE FUNCTION IN A POPULATION-BASED STUDY - THE ROTTERDAM STUDY [J].
BRETELER, MMB ;
VANSWIETEN, JC ;
BOTS, ML ;
GROBBEE, DE ;
CLAUS, JJ ;
VANDENHOUT, JHW ;
VANHARSKAMP, F ;
TANGHE, HLJ ;
DEJONG, PTVM ;
VANGIJN, J ;
HOFMAN, A .
NEUROLOGY, 1994, 44 (07) :1246-1252
[4]   Brain microvascular changes in Alzheimer's disease and other dementias [J].
Buee, L ;
Hof, PR ;
Delacourte, A .
CEREBROVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE, 1997, 826 :7-24
[5]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[6]  
DELATORRE JC, 1993, NEUROL RES, V15, P146
[7]   Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience .15. [J].
Ellis, RJ ;
Olichney, JM ;
Thal, LJ ;
Mirra, SS ;
Morris, JC ;
Beekly, D ;
Heyman, A .
NEUROLOGY, 1996, 46 (06) :1592-1596
[8]   LACK OF DIFFERENCE IN BRAIN HYPERINTENSITIES BETWEEN PATIENTS WITH EARLY ALZHEIMERS-DISEASE AND CONTROL SUBJECTS [J].
ERKINJUNTTI, T ;
GAO, FQ ;
LEE, DH ;
ELIASZIW, M ;
MERSKEY, H ;
HACHINSKI, VC .
ARCHIVES OF NEUROLOGY, 1994, 51 (03) :260-268
[9]   Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia [J].
Gold, G ;
Giannakopoulos, P ;
MontesPaixao, C ;
Herrmann, FR ;
Mulligan, R ;
Michel, JP ;
Bouras, C .
NEUROLOGY, 1997, 49 (03) :690-694
[10]   ALCOHOL AND TOBACCO CONSUMPTION AS RISK-FACTORS FOR ALZHEIMERS-DISEASE - A COLLABORATIVE REANALYSIS OF CASE-CONTROL STUDIES [J].
GRAVES, AB ;
VANDUIJN, CM ;
CHANDRA, V ;
FRATIGLIONI, L ;
HEYMAN, A ;
JORM, AF ;
KOKMEN, E ;
KONDO, K ;
MORTIMER, JA ;
ROCCA, WA ;
SHALAT, SL ;
SOININEN, H ;
HOFMAN, A .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1991, 20 :S48-S57